Graphic: 7 Biosimilars OK’d by FDA

The U.S. Food and Drug Administration to date has approved seven biosimilars, including Zarxio, Inflectra and Erelzi.

A rundown on the seven biosimilars can be seen at left.

(Graphic courtesy of Center for Biosimilars)

You might also be interested in:

Some Top Quotes From National Policy and Advocacy Summit on… April 30, 2018
FDA Moves on Biosimilars, Outlines New Plans December 15, 2018
Gottlieb’s Full Statement on New FDA Efforts to Prop… June 14, 2018
FDA Green Lights First Epoetin Alfa Biosimilar for Anemia May 16, 2018
Center for Biosimilars Offers Key Biosimilars Takeaways from… May 30, 2018
How Will the FDA’s Payer Communications Guidance Affect… July 18, 2018
FDA Finalizes Communications Guidances June 16, 2018